Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis

NCT00151801 is registered in ClinicalTrials.gov with S. Andrea Hospital as lead sponsor.

NCT NCT00151801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00151801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability of Oral Two-Doses Estroprogestins Associated With Interferon-Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Lead sponsor
S. Andrea Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
May 31, 2002
Completion date
December 31, 2008
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis